Key advances in the clinical studies of ANCA-associated vasculitis
10.16571/j.cnki.1008-8199.2016.03.022
- VernacularTitle:抗中性粒细胞胞浆抗体相关性血管炎的临床研究进展
- Author:
Xia LIU
;
Weixin HU
- Publication Type:Journal Article
- Keywords:
Anti-neutrophil cytoplasmic antibodies;
ANCA-associated vasculitis;
Classification;
Assessment;
Treatment
- From:
Journal of Medical Postgraduates
2016;29(3):323-326
- CountryChina
- Language:Chinese
-
Abstract:
Anti-neutrophil cytoplasmic antibodies( ANCA)-associated vasculitis ( AAV) has various clinical symptoms, thus various treatment schemes were used in clinics.To date, there has been no validated diagnostic criteria or treatment guideline for AAV.There are three aspects to be considered when assessing the treatment with AAV patients:staging of disease, distinction between disease activity and chronic damages, and quality of life ( QOL) .This review focuses on the latest classification of vasculitis, the rela-tion between disease stages and its severity, the importance of distinguishing active diseases from permanent damages, the therapeutic choices and the management of complications.
